Space company Astra going private to avoid bankruptcy after dismal public run

Space company Astra going private to avoid bankruptcy after dismal public run


Rocket LV0006 tilts during liftoff.

Astra / NASASpaceflight

Space company Astra will go private in a cut-rate deal with its founders after a dismal run as a publicly-traded stock.

Astra co-founders Chris Kemp and Adam London – CEO and CTO, respectively – signed an agreement with the company’s board to acquire all outstanding common stock at 50 cents a share. The deal is expected to close in the second quarter.

A special committee of the board, with Kemp and London abstaining, voted in favor of the take-private plan. After the founders last month cut their offer from $1.50 a share to 50 cents, the board’s committee emphasized it believed the deal was “the only alternative” to filing for Chapter 7 bankruptcy.

Astra’s stock, halted at 85 cents a share near the time of the announcement, closed at 58 cents a share Thursday.

The company’s market value is about $13 million at current levels, a sliver of the $2.6 billion equity valuation it went public at via a SPAC three years ago.

Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

The San Francisco-area company, incorporated in 2016, once aimed to mass produce small rockets and conduct launches as often as daily.

Since its stock debut, Astra’s rockets reached orbit twice – but the company also suffered three launch failures.

An Astra Spacecraft Engine during testing.

Astra

Its rocket-launching business has been on hiatus since a June 2022 mission failure. Despite acquiring a spacecraft propulsion business, the company was unable able to drive meaningful quarterly revenue and conducted layoffs last year in a bid to survive.

The company recorded more than $750 million in net losses since announcing it would go public.



Source

Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More
Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices
Business

Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices

A customer shops for Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas.  Brandon Bell | Getty Images The scariest thing haunting Halloween this year isn’t a ghost, goblin or ghoul — it’s the price of chocolate. From Snickers to Reese’s to Twix, one of America’s favorite indulgences is getting more […]

Read More